In an age of increasingly personalized healthcare, Elizabeth Philp has become a significant force of innovation, especially in the fast-evolving field of compounded pharmacy. As the co-founder and CEO of Roseway Labs, Philp is at the helm of a movement to make bespoke medications more obtainable, disrupting the standard one-size-fits-all approach